NasdaqCM:AXGNMedical Equipment
Is Axogen (AXGN) Still Below Fair Value As Strong Q2 Results Lift Guidance?
Why Axogen Stock Is Back in Focus After Q2 Earnings
Axogen (AXGN) is back on investor watchlists after its second quarter 2026 earnings report, which combined higher sales with a net loss, along with raised full year revenue guidance and expectations for continued positive free cash flow.
See our latest analysis for Axogen.
The strong second quarter update, raised 2026 revenue guidance and expectation for continued positive free cash flow help explain why Axogen's share price return is up...